Rivaroxaban-induced acute pancreatitis

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

The European Research Journal
Volume:5 Issue:3
Rivaroxaban-induced acute pancreatitis

Rivaroxaban-induced acute pancreatitis

Authors : Özgür SİRKECİ, Emel ERKUŞ SİRKECİ, Belma TAŞEL

Pages : 569-571

Doi:10.18621/eurj.417972

View : 14 | Download : 13

Publication Date : 2019-05-04

Article Type : Other Papers

Abstract :Rivaroxaban is a direct factor Xa inhibitor and has been safely used since 2008. It is used for the detection of atrial fibrillation and venous thromboembolism. Pancreatitis is one of the rare but dangerous side effects of rivaroxaban. The case of a 53-year-old female patient that developed in the third month of drug usage was evaluated, and it was confirmed after a full analysis was conducted that excluded all other factors, such as biliary calculus, alcohol usage, hypertriglyceridemia, biochemical parameters, ultrasonography and computed tomography that the patient’s condition was caused by the use of Rivaroxaban. The aim of this case presentation is to indicate that awareness should be increased regarding the risks of using the drug Rivaroxaban, as it could lead to drug-induced pancreatitis, even though this is rare.
Keywords : drug induced pancreatitis, rivaroxaban, drug safety

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.